2. Academic Validation
  3. Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach

Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach

  • J Med Chem. 2009 Aug 27;52(16):4981-5004. doi: 10.1021/jm9002395.
Rongshi Li 1,  Alan Pourpak,  Stephan W Morris
Affiliations

Affiliation

  • 1 Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, Oncologic Sciences, University of South Florida, 12902 Magnolia Drive, Tampa, FL 33612, USA. Rongshi.Li@moffitt.org
PMID: 19610618 DOI: 10.1021/jm9002395
Figures